Diabetes

Earn up to 3 CPD points per module

Breaking through convention to simplicity in type 2 diabetes care

Breaking through convention to simplicity in T2DM care – Case study 3

Breaking through convention to simplicity in type 2 diabetes care – Case study 2

Bolstering early glycaemic control – Advances in diabetes care

American College of Cardiology Update 2024

Breaking through convention to simplicity in type 2 diabetes care – Case study 1

Second-generation basal insulins improve glycaemic control

Case study 3 – A type 2 diabetes patient with kidney disease

Case study 2 – Poorly controlled T2DM patient with a high cardiovascular risk profile

Case study 1 – Treating the type 2 diabetes patient to improve overall metabolic profile

Combination therapy in dyslipidaemia – A practical approach

The intermittent fasting revolution – its value for your T2DM patient

START – The transition to insulin Copy

Breaking through the complexity of managing type 2 diabetes

Type 2 diabetes and ASCVD

The revolution in type 2 diabetes – Obesity and new therapies

The patient’s journey with dulaglutide – Type 2 diabetes clinical cases

Breaking through the complexity of managing type 2 diabetes – Case study 3

Breaking through the complexity of managing type 2 diabetes – Case study 2

Breaking through the complexity of managing type 2 diabetes – Case Study 1

Breaking through the complexity of diabetes management and improving cardiovascular health through lipid management

Primary prevention of diseases of ageing – Use the benefits of menopausal hormone therapy

Chronic illness and Ramadan fasting – Optimal management for patients intending to fast

Weight loss case studies: Metabolic syndrome and regular travel, adolescence, and PCOS

Time in range – What is it, and does it matter?

Cardiometabolic syndrome – new approaches

European Association for the Study of Diabetes (EASD) congress 2022

From science to clinical practice – lessons from REWIND

Insulin – A call to action: Case studies in type 2 diabetes

Early intervention in type 2 diabetes to reduce kidney and cardiovascular complications

Unmet needs in the management of diabetic kidney disease in type 2 diabetes and hypertension in sub-Saharan Africa

The complex interplay between COVID-19 and diabetes

The heart and diabetes – Is pre-diabetes a treatable entity?

Type 1 diabetes: using time-in-range to compare Gla-300 and IDeg-100

Managing type 2 diabetes with IDegLira: A real world perspective

Adolescents with obesity: Weight stigma and other barriers to treatment

Issues and Answers: Practical guidance on managing adolescent obesity

Diabetes and Ramadan – fasting diabetic patients

Diabetes and Ramadan – practical insulin management

Rethinking primary CVD prevention in type 2 diabetes today

Diabetes care – a journey of innovation and partnerships

Endocrine Symposium focuses on Type 1 diabetes

Simplicity and control – cardiometabolic effects of GLP-1 receptor agonists in type 2 diabetes

The best treatment options for type 2 diabetes in 2020

Early prevention and management of heart failure in T2DM patients

GLP-1 RAs and cardiovascular protection for your type 2 diabetes patient

Diabetes and Ramadan – A case for safer fasting using oral antidiabetic drugs

Cardiovascular protection in the treatment of type 2 diabetes

Diabetes and Ramadan – practical guidance to ensure a safer fast

‘Diabesity’ – interlinking treatments to improve outcomes in diabetes and obesity

Diabetes and Ramadan practical guidelines

COVID-19 and Diabetes: A new model of diabetes care

Case study 3 – A diabetic patient with COVID-19

Case study 2 – The treatment of a newly diagnosed diabetic patient

Case Study 1 – How would you treat this prediabetic patient?

START Module 5: Making patients partners in their care

START Case Study 3: Intensifying and switching insulins

START Module 1: Initiating insulin

START Module 2: Insulins: An introduction

START Module 3: Insulin initiation in type 2 diabetes

START Module 4: Intensifying insulin

START Case Study 2: The transition to insulin

START Case Study 1: Effectively starting patient insulin therapy

ACT 6: SGLT-2 inhibitors and safety

ACT 5: Renal benefits of SGLT-2 inhibitors in diabetes

ACT 4: Review of renal therapies prior to SGLT-2 inhibitor therapy

ACT 3: Renal protection in diabetes

ACT 2: Cardiovascular outcome trials in diabetes

ACT 1: Cardiovascular and renal protection in diabetes

Type 2 diabetes target the cardiorenal system

Type 2 diabetes and the kidneys

EULAR 2021: What’s new in Rheumatology

Type 2 diabetes: Overcoming multifaceted pathophysiology and barriers to glycaemic control

The importance of individualised approach to the treatment of T2DM

Pharmacotherapy for the management of obesity

A five-step guideline approach to obesity management

Practical Obesity Management

European Association for the Study of Diabetes (EASD) 2021 virtual congress highlights

Anti-VEGF Agents – The Importance of Early Switching when Treatment Fails

START – The transition to insulin